3
Announcements
Trials
Browse
Landscape
Status
Completed
5
Recruiting
3
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Peripheral Nervous System Diseases
2
Pain
2
Mesothelioma
2
Lung Neoplasms
2
Warts
1
Prostatic Neoplasms
1
Pleural Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Musculoskeletal Pain
1
Ganglion Cysts
1
Cancer Pain
1
Breast Neoplasms
1
Abdominal Pain
1
Interventions
Docetaxel
56
Prednisone
36
enzalutamide
25
Leuprolide
24
Magnetic Resonance Spectroscopy
19
Abiraterone Acetate
19
bicalutamide
17
Radiotherapy
15
Goserelin
15
abiraterone
12
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
11
olaparib
9
Androgen Antagonists
9
gallium 68 PSMA-11
8
cabazitaxel
8
Radiotherapy, Intensity-Modulated
8
Metformin
8
Ketoconazole
8
Gonadotropin-Releasing Hormone
8
Cyclophosphamide
8
apalutamide
7
Doxorubicin
7
luprolide acetate gel depot
6
cabozantinib
6
Radiosurgery
6
Estramustine
6
Dexamethasone
6
Calcitriol
6
Biopsy
6
pembrolizumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Prostatic Neoplasms
×
Cryotherapy
×
Clear all
NCT00824928
2015-05-27
SCORE
University of Colorado, Denver
Terminated
60 enrolled